The Different Types Of Acne Medication

8 Jan 2009 at 8:25am 

To treat acne, there exists many types of Read more...

Quinnova Pharmaceuticals introduces Neosalus - Pharmaceutical Business Review

8 Jan 2009 at 4:46am 

Quinnova Pharmaceuticals introduces Neosalus Pharmaceutical Business Review - Jan 8, 2009 By Staff Writer Christopher Hensby, senior vice president of Quinnova, said: "To treat recalcitrant skin conditions such as atopic dermatitis and hand ...

Read more...

SkinMedica Launches On-Line Service for Physician Partners - PR Newswire (pre...

7 Jan 2009 at 4:03pm 

SkinMedica Launches On-Line Service for Physician Partners PR Newswire (press release), NY - Jan 7, 2009 SkinMedica's Desonate(R) (desonide) Gel 0.05% is indicated for the treatment of mild-to-moderate atopic dermatitis; EpiQuin(R) Micro (4% hydroquinone) cream ...

Read more...

Easy Skin Care For Your Pet

7 Jan 2009 at 3:21pm  Pets suffer from many problems that can affect their skin. Skin functions as a barrier to protect the body from infection, ultra violet light and dehydration. It is the largest organ in the body. Prop...

Read more...

SkinMedica Launches On-Line Service for Physician Partners - Earthtimes

7 Jan 2009 at 1:06pm  Author : SkinMedica, Inc. "Our commitment to clinical skin care includes excellent products, superior account representation, and top-quality education," said Ted Schwarz , Senior Vice President and General Manager, Aesthetics Division. "We are ...

Read more...

Galderma Announces Availability of Epiduo Gel, the First and Only ... - Phra...

6 Jan 2009 at 9:11am  FORT WORTH, Texas, January 06, 2009 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the availability of Epiduo(TM) (adapalene and benzoyl peroxide) Gel 0.1% / 2.5%, the first and only, once-daily, topical acne treatment that combines the ...

Read more...

Provectus Pharmaceuticals Updates Shareholders on 2008 Accomplishments - Phra...

6 Jan 2009 at 8:28am  Clinical Trials Progress for Therapeutic Platforms Based Upon Proprietary Formulations of Rose Bengal- -Trials in Progress Include Metastatic Melanoma, Recurrent Breast Cancer and Atopic Dermatitis- KNOXVILLE, Tenn.--(BUSINESS WIRE)--Jan 6, 2009 ...

Read more...

Provectus Pharmaceuticals Updates Shareholders on 2008 Accomplishments - Busi...

6 Jan 2009 at 6:01am 

Provectus Pharmaceuticals Updates Shareholders on 2008 Accomplishments Business Wire (press release), CA - Jan 6, 2009 In May Provectus Began a Phase 2 Clinical Trial of PH-10, a Topical Formulation of Rose Bengal for Dermatology, for Atopic Dermatitis. ...

Read more...

YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE ... - PR News...

5 Jan 2009 at 4:33pm 

YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE ... PR Newswire (press release), NY - Jan 5, 2009 Unrelated to the rash, Grade III/IV radiation dermatitis is a severe toxicity reported in almost half the patients treated with another EGFR-targeting ... YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III ... Reuters all 44 news articles

Read more...

YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED - MSN MoneyCentral

5 Jan 2009 at 4:07pm  MISSISSAUGA, ON , Jan. 5 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that it ...

Read more...